Buy Ipamorelin 10 mg in Australia
In Australia, Ipamorelin 10 mg costs $84.99 from Australian Research Peptides, which supplies it to laboratories and researchers as a sealed vial of freeze-dried powder, but it is out of stock for the moment. Independently lab-tested before release, Ipamorelin is a synthetic pentapeptide binding the growth hormone secretagogue receptor. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, with two mirror-image D-residues and an amide terminus, and no run of five in any human protein matches it. It is studied in growth hormone and gastrointestinal motility research. In vitro research only, never for human or veterinary use.
GHRH and Secretagogue Research · Lyophilised Powder · Independently lab-tested · SKU 41773
$84.99
Presentation
10 mg per vial
Grade
Research Grade
Form
Lyophilised Powder
Category
GHRH and Secretagogue Research
Currently out of stock — stocked lines dispatch same business day before 12pm Sydney time, Mon–Fri
Tracked shipping Australia-wide ·typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. ARP gives no usage, medical or therapeutic guidance of its own.
Ipamorelin · 10 mg
$84.99
In stock instead: CJC-1295 (no DAC) + Ipamorelin 10 mg
Ipamorelin is out of stock, but our CJC-1295 (no DAC) + Ipamorelin contains it and is on the shelf here in Australia.
View CJC-1295 (no DAC) + Ipamorelin 10 mgBrowse all GHRH and Secretagogue Research
About Ipamorelin
Ipamorelin is described in the literature as binding the growth hormone secretagogue receptor and activating it. Ghrelin is the hormone that normally binds there, which is why the literature also calls ipamorelin a ghrelin mimetic. The 1998 study that introduced the compound tested it in three systems: isolated rat pituitary cells, anaesthetised rats and conscious pigs. A later rat study examined the same receptor in gastrointestinal motility research.
Ipamorelin is a pentapeptide, a chain of five amino acids, with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. Two of the five sit in the mirror-image D-configuration, and three are residues you would not find in an ordinary protein. The chain ends in an amide rather than a free acid. Nothing in that sequence corresponds to a fragment of a human protein, so the molecule is fully synthetic. Its development code is NNC 26-0161.
Australian Research Peptides lists ipamorelin twice, and the difference matters when you order. This page is the single-compound vial, where the whole of the stated quantity is ipamorelin. It appears again as one half of CJC-1295 (no DAC) + Ipamorelin, which holds two different peptides in one vial. Those are separate listings with separate batch records.
BAC water (bacteriostatic water) is also in our range.
The peptide calculator works out the mg/mL concentration of a reconstituted vial.
Content reviewed
Further reading: Peptide Types, Categories and Blends · Where Is the Best Place to Buy Peptides in Australia? · Ipamorelin in Australia: What It Is and How It Is Tested
Ipamorelin specifications, storage and shipping
- Compound: Ipamorelin
- Also known as: Ipamorelin (NNC 26-0161)
- Class: Synthetic pentapeptide; growth hormone secretagogue receptor agonist
- Appearance: White to off-white lyophilised powder
- Sizes & SKUs: 10 mg (41773)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: Research grade
- Testing: Independently lab-tested before release
- Identity confirmation: Mass spectrometry
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
Ipamorelin is independently lab-tested before release. No laboratory report is published for this line yet. The COA library lists every product and strength, and says which reports are available.
This line is currently out of stock. Stocked lines ordered before 12pm Sydney time on a business day are dispatched the same day with tracked shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about Ipamorelin
This question guide from Australian Research Peptides covers Ipamorelin in Australia: what the listing contains, live buying and delivery questions, research context, handling, testing and comparisons. Start with the quick answers, then open the topic group that matches your search.
Buying, price and availability
Ipamorelin is listed and dispatched in Australia by Australian Research Peptides, in its GHRH and Secretagogue Research range. This pentapeptide is independently lab-tested before release, and the CoA library names the products and strengths a certificate has been published for. ARP posts from within Australia, so delivery is domestic: Express Post or standard tracked, to any state or territory in the country. Hit the 12pm Sydney time weekday cut-off, once a vial is available, and it is packed and away the same day.
Ipamorelin arrives as a dry five-amino-acid powder with no liquid in the vial, and most laboratories dissolve it in an aqueous diluent. The diluent is simply the liquid used to bring powder back into solution. None of it comes in the vial, because the peptide is supplied dry.
Ipamorelin is not a registered medicine in Australia or in any other country, so there is no Australian prescription product containing it. Australian Research Peptides supplies it to laboratories and researchers as research material for in vitro use.
Ipamorelin has no marketing approval in any country, so there is no approved overseas product to import under a personal-importation exemption — which makes it a harder case than compounds licensed elsewhere. The TGA governs what unapproved goods may enter and Border Force applies it at the frontier. Australian Research Peptides holds Ipamorelin in Australia, so the vials never cross a border and an order waits on no clearance — which is why domestic supply is quicker than importing. It is worth being plain about what that does and does not settle: it settles how the parcel travels, not what the material is or what its holder is responsible for.
Testing on Ipamorelin establishes identity. Mass spectrometry confirms the material weighs what Ipamorelin should weigh. The result belongs to the batch tested rather than to the product line as a whole. Ipamorelin is supplied to laboratories and researchers for in vitro research purposes only.
Identity, names and exact format
A secretagogue is anything that makes a cell secrete something. A growth hormone secretagogue makes pituitary cells release growth hormone. The receptor involved carries two names in the literature, growth hormone secretagogue receptor and ghrelin receptor, and both refer to the same protein. Ipamorelin is described as an agonist at that receptor — it binds there and switches it on — which is the class its specification records.
Ipamorelin is a synthetic peptide of five amino acids, classed as a growth hormone secretagogue receptor agonist — a molecule that binds and activates that receptor, the same one ghrelin occupies. Raun's 1998 characterisation at Novo Nordisk is the paper the literature keeps returning to. Australian Research Peptides supplies the pentapeptide as a lyophilised 10 mg vial for in vitro research.
An Ipamorelin vial holds one substance and nothing else. The molecule is freeze-dried into a dry powder, and no filler, stabiliser, carrier or partner peptide shares the glass with it. The sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, which is where the three unusual amino acids sit. The vial is sealed and tamper-evident, with the quantity printed on the label.
Ipamorelin is a pentapeptide supplied at ten milligrams, and that much freeze-dried material presents as a scant residue rather than a filled container. Short chains pack down hard while the frozen water is drawn off as vapour, giving a dense, thin cake instead of a fluffy one. Rotating the glass under strong light is how most people find it. A sparse-looking vial says nothing about being underfilled.
Research context and evidence
Ipamorelin is reported to activate the growth hormone secretagogue receptor, which is why it is classed as an agonist there. An agonist binds a receptor and activates it, as opposed to blocking it. Raun and colleagues demonstrated that activity in isolated rat pituitary cells in 1998. Later rat work found the same receptor on the cholinergic nerve cells of the gut — the nerves that drive movement through the bowel — which is how the compound reached gastrointestinal research.
Ipamorelin research in laboratory and animal models measures the growth hormone response itself: how much growth hormone is released, in what pattern, and how steadily that release holds. Those are measurements of a hormone signal, not an outcome in a person. Ipamorelin is supplied to laboratories and researchers for laboratory use.
Ipamorelin contains five amino acids, which is what the word pentapeptide records. Penta means five, and peptide means a chain of amino acids joined end to end. Three of the five are non-standard amino acids and two are mirror-image D-forms. The chain closes with an amide group, not a free acid. No human protein contains that run of five, so ipamorelin is not cut out of a larger natural chain.
Ipamorelin restocks are not run to a published schedule, so no date exists to check back against. Australian Research Peptides emails a stock alert to anyone who has registered for one, sent the moment a batch is released for sale rather than in a later marketing round. That email is the only reliable signal that the pentapeptide is available again.
Ipamorelin carries two aromatic residues, D-phenylalanine and D-2-naphthylalanine, and aromatic side chains are what light acts on. Keep the unopened vial in a freezer at −20 °C, shielded from light and moisture. Once dissolved it moves to a fridge at 2–8 °C and stays usable for eight to twelve weeks. Warm a cold vial while it is still sealed, or room air condenses water into the powder.
Ipamorelin is reconstituted by dissolving its freeze-dried powder in a suitable diluent. Bring the unopened vial up to room temperature before breaking the seal, so no moisture condenses on cold powder. Run the liquid in slowly against the glass wall instead of dropping it onto the cake. Swirl until clear, never shake, because shaking foams peptide solutions. The volume decides the strength you finish with.
Reconstituted Ipamorelin is kept at 2–8 °C and finished within twelve weeks, eight being the safer read, under Australian Research Peptides' operating figure. Three of its five amino acids are non-standard, two of them mirror-image D-forms, a build that resists being broken apart by enzymes in a laboratory test — which says nothing about a vial in a fridge. Nothing measuring dissolved Ipamorelin over time has appeared in print.
Australian Research Peptides publishes no fill volume for the 10 mg Ipamorelin vial, and there is no single correct one. How much diluent goes into the glass is a decision for the work rather than something the listing sets, and it changes the concentration, not the 10 mg of peptide.
Handling, storage and measurements
Ipamorelin comes from Australian Research Peptides Pty Ltd — ARP for short — which carries it in a single 10 mg strength. Typing nnc 26-0161, or a common misspelling of the name, finds the listing anyway. No vial is available to pack right now; when one is, an order landing before 12pm Sydney time is packed that business day, and the parcel travels Express or tracked Standard post to any state or territory — never across a border. Ipamorelin is independently lab-tested, and the CoA library states which strengths a published certificate is available for.
One Australian-dollar figure covers Ipamorelin, quoted per vial, because Australian Research Peptides lists the pentapeptide in a single 10 mg strength. That figure is held in the compound's live catalogue record rather than hard-typed into copy, so it cannot fall out of date. Postage is charged separately and is never included in the vial price.
It takes three Ipamorelin vials to reach free Standard tracked post, because this is one of the lower-priced lines in the range. Four reach the Express Post waiver. Many orders get there another way, by adding a second compound such as the CJC-1295 blend. Qualification is judged on the goods subtotal, before any discount code.
Ipamorelin is sold online by Australian Research Peptides and is not taken over the phone or by email. Delivery is to an Australian address only; nothing is sent abroad. PayID and bank transfer are the two accepted methods, and each payment needs the order's reference in its description so it can be matched.
Ipamorelin sent by Express Post reaches the quickest states in 1–2 business days and the slowest in up to four; standard tracked post is a 2–5 day window and costs less. Both services are tracked end to end. Neither changes when the parcel is dispatched — only how quickly it travels afterwards.
PayID and bank transfer differ on one axis that matters when paying for Ipamorelin: speed. PayID moves through the New Payments Platform and usually settles within minutes at any hour. A standard transfer can queue until the next business day and longer across a weekend. Both are accepted for Ipamorelin; only one reliably makes the same-day cut-off.
A 10 mg Ipamorelin vial is normally dissolved in one step, with the whole freeze-dried cake going into solution at once and the volume chosen setting the concentration. Small volumes of the made-up stock solution are then measured with the laboratory's own graduated equipment, so the vial itself is entered as little as possible.
Ipamorelin carries no approval in any country and holds no marketing authorisation from the Food and Drug Administration, the Therapeutic Goods Administration or any other medicines regulator. Novo Nordisk discovered the pentapeptide and later work on it was run by Helsinn; the programme was discontinued and nothing was ever submitted for registration. What Australian Research Peptides supplies is unregistered research powder, labelled for in vitro research purposes only.
Ipamorelin is banned in sport at all times: WADA's Prohibited List places it in the growth hormone secretagogue category, which is prohibited both in and out of competition. Sport Integrity Australia administers that list in Australia. Australian Research Peptides supplies Ipamorelin to laboratories and researchers for in vitro research only.
Ordering, payment and Australian delivery
Yes — Ipamorelin is independently lab-tested before it goes on sale at Australian Research Peptides, by a laboratory hired by the manufacturer. Spectrometry weighs the molecule and compares that against what this five-amino-acid chain ought to weigh. No matching certificate is currently published for this product and strength.
Ipamorelin is also known as NNC 26-0161, its original development code, and Australian Research Peptides prints both together in the specification as Ipamorelin (NNC 26-0161). Sequence-based references write it Aib-His-D-2-Nal-D-Phe-Lys-NH2. Papers group it with the growth hormone secretagogues, though it is not GHRP-2 or GHRP-6 and those names belong to other molecules. Buyers abbreviate it to ipam or ipa, and the usual misspellings resolve on site search too. Whatever you typed, ARP supplies the vial behind it from within Australia, so the parcel travels domestically rather than clearing an import step.
Ipamorelon and ipamoralin are common mistypings of Ipamorelin rather than separate compounds: the same five-amino-acid chain, the same single-peptide vial, and no difference in what Australian Research Peptides lists under the correct spelling. Neither is a second name for the compound — both are keyboard slips, and the peptide behind them is the same one. The difference is one vowel each time — an a where ipamorelin carries an e, an o where it carries an i.
Australian Research Peptides’ standalone Ipamorelin listing holds that peptide alone, so the whole stated quantity is one compound. The other listing puts two peptides in one vial, CJC-1295 without DAC alongside ipamorelin, freeze-dried together as a single powder. They are separate catalogue lines carrying separate batch records. The overlap is in the name only, not in what the glass holds.
Access and regulatory questions
Ipamorelin is a single agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor. CJC-1295 (no DAC) is a structurally unrelated peptide that binds the GHRH receptor instead, so the pre-blended vial puts two different molecules with two separate receptor targets in one glass. Australian Research Peptides lists the blend for work on both targets and the standalone pentapeptide for work on one.
Ipamorelin comes from Australian Research Peptides; Chemist Warehouse does not stock it and it is not a pharmacy product anywhere in Australia. Without a marketing authorisation there is no registered Ipamorelin product for a pharmacy to stock or dispense, which rules out every retail chain rather than just one. ARP catalogues it as a 10 mg research vial under GHRH and Secretagogue Research.